Search

Ocular Therapeutix Inc

Închisă

SectorSănătate

9.03 -1.1

Rezumat

Modificarea prețului

24h

Curent

Minim

8.85

Maxim

9.11

Indicatori cheie

By Trading Economics

Venit

-24M

-89M

Vânzări

-2.5M

11M

EPS

-0.4

Marjă de profit

-821.623

Angajați

325

EBITDA

-24M

-85M

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+184.28% upside

Dividende

By Acuity

Următoarele câștiguri

4 aug. 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

95M

2.2B

Deschiderea anterioară

10.13

Închiderea anterioară

9.03

Sentimentul știrilor

By Acuity

41%

59%

123 / 340 Clasament în Healthcare

Ocular Therapeutix Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

17 iul. 2026, 23:56 UTC

News
Social Media

Micron Technology shares are lower in after-market trading amid a decline in India's smartphone shipments and ongoing memory cost pressures affecting margins.

17 iul. 2026, 23:36 UTC

News

GameStop increased its stake in eBay to nearly 10%, acquiring 3.5 million shares for about $381 million. eBay shares are gaining in after-market trading.

17 iul. 2026, 23:36 UTC

Macro News
News
ETF Constituents

Vanguard Information Technology ETF rises slightly in after-market trading, supported by gains in Microsoft, Analog Devices, Adobe, Qualcomm, and Snowflake.

17 iul. 2026, 23:21 UTC

Social Media
News
Correlated Moves

Meta Platforms Inc. shares declined in after-market trading amid concerns over $125 billion to $145 billion in projected AI spending and slower development timelines.

17 iul. 2026, 23:16 UTC

News

United Airlines reported record Q2 revenue of $17.7 billion, a 16% increase. Shares were little changed during after-market hours following the announcement.

17 iul. 2026, 23:16 UTC

News
Social Media

PayPal Holdings Inc shares are lower in after-market trading amid reports of a potential bid, though analysts remain cautious about growth prospects.

17 iul. 2026, 23:16 UTC

News
ETF Constituents
Macro News
Correlated Moves

GDX trades higher in after-market hours, supported by positive analysis and strong performance expectations amid rising geopolitical tensions and crude oil prices.

17 iul. 2026, 23:06 UTC

News

Baidu Inc. partners with Apple to enhance its AI capabilities and pursues a dual-primary listing in Hong Kong, shares higher in after-market trading.

17 iul. 2026, 23:06 UTC

ETF Constituents
News

Vanguard Growth ETF trades lower in after-market hours, continuing a downward trend. Top holdings META, AMAT, and LLY negatively impacted performance.

17 iul. 2026, 20:07 UTC

News
Social Media

European Union approval is anticipated for the $55 billion acquisition of Electronic Arts by a group of investors, including Saudi Arabia's Public Investment Fund.

17 iul. 2026, 20:07 UTC

News
Social Media

Tesla Inc shares are lower as investors await the earnings report on July 22. Concerns over Semi truck rollout and autonomous driving goals weigh on sentiment.

17 iul. 2026, 20:07 UTC

Macro Event
Social Media
Correlated Moves
News

Broadcom shares declined to around $371.69 today, amid increased bearish sentiment and concerns over potential breakdowns below key support levels.

17 iul. 2026, 20:07 UTC

News

Ethereum is trading lower as geopolitical tensions and rising oil prices heighten inflation concerns. Ongoing worries about tech valuations also impact its performance.

17 iul. 2026, 20:07 UTC

News

Bitcoin is rising during Friday's session amid geopolitical tensions and rising oil prices, though it has pulled back from earlier session highs.

17 iul. 2026, 20:07 UTC

News
Macro Event

Geopolitical tensions and rising oil prices support Bitcoin's gains during Friday's session, despite earlier pullbacks and regulatory scrutiny from former President Trump.

17 iul. 2026, 20:03 UTC

News

J B Hunt shares are lower as freight shipments decline and inflationary pressures persist. The Cass Freight Index reported a 4.1% year-over-year drop in June.

17 iul. 2026, 20:03 UTC

News
Social Media
Correlated Moves

Western Digital Corp shares are higher, supported by projected revenue growth of 43.7% and improved operating margins, despite earlier volatility and a pullback from session highs.

17 iul. 2026, 20:03 UTC

News
Macro Event

Ulta Beauty is gaining as Evercore highlights its innovation amid positive consumer sentiment data, despite an earlier pullback from session highs.

17 iul. 2026, 20:03 UTC

Correlated Moves
News
Social Media

Alphabet Inc. shares are declining amid reports of delays in the Gemini project rollout, overshadowing BMO's price target increase to $455.

17 iul. 2026, 20:03 UTC

News
Correlated Moves
Social Media

Alphabet Inc shares are lower amid a securities fraud investigation and delays in its AI model rollout. BMO raised its price target to $455.

17 iul. 2026, 20:02 UTC

News

Wynn Resorts Ltd is lower amid broader market declines and a negative outlook from StockStory, citing financial challenges and modest sales growth.

17 iul. 2026, 20:01 UTC

News

NetApp Inc. shares are higher as StockStory highlights a $177.25 price target and strong growth in billings and earnings per share.

17 iul. 2026, 19:56 UTC

News

Gilead Sciences shares are lower as the company missed full-year EPS estimates despite reporting $6.96 billion in revenue, reflecting heightened market volatility.

17 iul. 2026, 19:56 UTC

News
Social Media

Apple Inc. is in early settlement discussions regarding an antitrust lawsuit. The company regained its status as the world's most valuable, surpassing Nvidia.

17 iul. 2026, 19:52 UTC

News
Social Media
Correlated Moves

NVIDIA shares are declining amid a broader semiconductor sell-off and competitive concerns from Moonshot AI's new model. Apple has surpassed NVIDIA in market value.

17 iul. 2026, 19:52 UTC

News
Correlated Moves

NXP Semiconductors NV is trading lower amid a broader market decline and rising pressures in the semiconductor industry, impacting its valuation narrative.

17 iul. 2026, 19:52 UTC

News
Social Media
Correlated Moves

AMD declines today amid broader market losses, pulling back from session high.

17 iul. 2026, 19:46 UTC

Social Media
News
Macro Event

Shares of American Airlines are lower today, trading around $15.03 amid increased bearish sentiment reflected in a rising put/call ratio of 1.61.

17 iul. 2026, 19:46 UTC

Social Media
Correlated Moves
News

CSX shares are lower as Daniel Loeb exits his 500,000-share position, following significant cuts in other railroad investments amid regulatory scrutiny.

17 iul. 2026, 19:46 UTC

News
Macro Event

Autodesk announces a collaboration with Amazon Web Services and raises revenue guidance to $8.5 billion, as shares gain during Friday's session.

Comparație

Modificare preț

Ocular Therapeutix Inc Așteptări

Obiectiv de preț

By TipRanks

184.28% sus

Prognoză pe 12 luni

Medie 25.5 USD  184.28%

Maxim 31 USD

Minim 18 USD

În baza a 9 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruOcular Therapeutix Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

9 ratings

9

Cumpărare

0

Păstrare

0

Vânzare

Sentiment

By Acuity

123 / 340 Clasament în Sănătate

Sentimentul știrilor

Evidențe de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Ocular Therapeutix Inc

Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology in the United States. The company markets DEXTENZA, a dexamethasone ophthalmic insert to treat post-surgical ocular inflammation and pain following ophthalmic surgery, as well as allergic conjunctivitis. It is developing AXPAXLI, an axitinib intravitreal implant that is in phase 3 trials for the treatment of wet age-related macular degeneration and other retinal diseases; PAXTRAVA, a travoprost intracameral implant, which is in phase 2 clinical trials for the treatment of open-angle glaucoma or ocular hypertension; OTX-CSI, a cyclosporine intracanalicular insert that has completed phase 2 clinical trials for the treatment of dry eye disease; and OTX-DED, a dexamethasone intracanalicular insert, which is in phase 2 clinical trials for the short-term treatment of the signs and symptoms of dry eye disease. In addition, the company offers modulator for intermediate and late dry age-related macular degeneration; and gene delivery for inherited retinal degenerations and protein biofactory indications. The company has a strategic collaboration with Regeneron Pharmaceuticals, Inc. (Regeneron) for the development and commercialization of products using the company's sustained-release hydrogel in combination with Regeneron's large molecule VEGF-targeting compounds for the treatment of retinal diseases; and AffaMed Therapeutics Limited for the development and commercialization of DEXTENZA and OTX-TIC. Ocular Therapeutix, Inc. was incorporated in 2006 and is headquartered in Bedford, Massachusetts.
help-icon Live chat